Effect of Super-Oxygenated Water on Blood Oxygen Saturation
Launched by INHALE, INC · Jun 3, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of drinking super-oxygenated water on blood oxygen levels in adult volunteers. Researchers believe that this special water could help deliver extra oxygen to the bloodstream non-invasively, which may support tissue repair and improve overall health. Participants in the study will be randomly assigned to either drink the super-oxygenated water or a regular placebo water, and neither they nor the doctors will know which one they are receiving. The study will measure their blood oxygen levels and heart rates before and after they drink the water.
To join the study, you must be at least 18 years old and willing to give written consent. You should be healthy enough to participate and not have any serious medical conditions, like heart or lung issues, that could interfere with the study. Women who are pregnant or nursing, or who have recently had major surgery, will not be eligible. If you decide to participate, you can expect to drink the water and have your oxygen levels monitored, helping researchers learn more about this potential new way to enhance oxygen delivery in the body.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Legally adult (18 years of age or older)
- • Subject must be willing to review and provide a written informed consent
- • Subject must agree to the study procedures including water ingestion, and SPO2 and heart rate measurements
- Exclusion Criteria:
- • Any active and life-threatening medical condition involving hepatic, renal, cardiac, respiratory, endocrine, or gastrointestinal systems, or any blood disorder in view of the Principal Investigator to confound the study
- • Female subjects those are pregnant, nursing or planning to become pregnant
- • Subjects receiving any experimental medications or have undergone a major surgical procedure in last 30 days
- • Subjects are excluded if they have previously utilized the test article (INHALE superoxygenated water) within the last 24 hours, or have undergone bariatric surgery or have received weight-loss medication
- • Subjects with known anemia, hemoglobinopathy or other comorbidity necessitating fluid restriction
About Inhale, Inc
Inhale, Inc. is a pioneering clinical trial sponsor specializing in the development of innovative inhalation therapies aimed at transforming the treatment of respiratory and systemic diseases. With a commitment to advancing pulmonary medicine, Inhale, Inc. leverages cutting-edge technology and robust clinical research methodologies to optimize drug delivery and enhance patient outcomes. The company's interdisciplinary team of scientists, clinicians, and regulatory experts collaborate closely to ensure the safety, efficacy, and compliance of their therapeutic products throughout all phases of clinical development. By focusing on patient-centric solutions and fostering strategic partnerships, Inhale, Inc. is dedicated to addressing unmet medical needs and improving the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Westlake Village, California, United States
Patients applied
Trial Officials
Deepak Nayak, PhD
Study Director
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported